US Dominates Global Weight-Loss Injection Trend; Low-Cost Jab Development on Horizon

The US is at the forefront of the weight-loss injection boom, with significant market growth noted. A new study suggests a potential for a $3/month weight-loss jab, making it accessible worldwide. Further research is needed to confirm efficacy and safety at this price point, which could revolutionize obesity management.